Skip to content
Home » Fluni

Fluni

    Fluni

    Fluni

    Fluni (Flunisolide 0.025%) is a 15ml nasal spray.

    Package contains: 1 pack of fluni contains 15ml of nasal spray approximately and an inner leaflet.

    Fluni

    Composition:

    Each ml contains:

    Flunisolide U.S.P 0.25mg

    Mfg. Vega Specs.

    Dosage: Use one to two sprays in each nostril two times a day or as directed by the physician.

    In adults: The usual starting dose is two sprays in each nostril twice daily. The physician may increase the dose to three times per day.

    In children: ages 5-12 years, the usual starting dose is one spray in each nostril three times per day or two sprays in each nostril twice daily. Children under 5 years: not recommended.

    Note: For full prescribing information see package insert.

    Indications: Fluni nasal spray is used for relieving symptoms associated with seasonal or perennial rhinitis due to allergies.

    Side Effects: The most common side effects following nasal inhalation of flunisolide are nasal irritation and itching, increased cough, nausea or vomiting, sore throat, nasal congestion, sneezing, nasal burning, bloody nasal discharge & dryness. Other adverse effects are headache, dizziness, watery eyes, and abdominal bloating.

    Contraindications: Hypersensitivity to any of the ingredients. Flunisolide nasal solution should not be used in the presence of untreated localized infection involving the nasal mucosa.

    Fluni back

    Warning: For nasal use only. Do not spray in eyes.

    Instructions: Store in cool dry place between 15°C to 30°C. Protect from heat and sunlight. Keep out of reach of the children.

    Manufactured by:

    Fluni nasal spray is manufactured by Vega Pharmaceuticals (Pvt.) Ltd. https://www.vegapharmaceuticals.com ^(https://medicineslist.com/goto/https://www.vegapharmaceuticals.com/)

    Fluni is not available online, you can get it from any pharmacy nearby you.

     

    By: Kainat Noor

    Leave a Reply

    Your email address will not be published. Required fields are marked *